A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Use of Allosteric Targets in the Discovery of Safer Drugs
2013
Medical Principles and Practice
The need for drugs with fewer side effects cannot be overemphasized. Today, most drugs modify the actions of enzymes, receptors, transporters and other molecules by directly binding to their active (orthosteric) sites. However, orthosteric site configuration is similar in several proteins performing related functions and this leads to a lower specificity of a drug for the desired protein. Consequently, such drugs may have adverse side effects. A new basis of drug discovery is emerging based on
doi:10.1159/000350417
pmid:23711993
pmcid:PMC5586781
fatcat:75jchqebifbvzccprwdwxq7n2y